Clinical Trial Update: Evaluation if Physostigmine Reduces Symptoms in Patients Who Has Developed a Delirium in Intensive Care After a Surgery [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating physostigmine for reducing delirium symptoms in ICU patients after heart surgery; the current trial status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Delirium

Drugs mentioned

• Physostigmine (physostigmine)

Snippet

Sponsor: PD Dr. Bertram Scheller | Conditions: Suspected Delirium After Elective or Emergency Heart Surgery, CAM-ICU Diagnosed Delirium | Phase 3 | Status: UNKNOWN